Monte Rosa Therapeutics (GLUE) Net Margin (2024 - 2026)
Monte Rosa Therapeutics (GLUE) recorded quarterly Net Margin of 1034.95% in Q1 2026, up 2.4% quarter-over-quarter from 1060.37% in Q4 2025, and down 109016.0% on a YoY basis from N/an in Q1 2025.
Monte Rosa Therapeutics (GLUE) Net Margin (2024 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Net Margin history runs 3 years deep, the most recent figure standing at 1034.95% for Q1 2026.
- In Q1 2026, Net Margin fell 109016.0% year-over-year to 1034.95%; the TTM figure through Mar 2026 stood at 2636.47% (down 264032.0% YoY), while the FY2025 annual figure was 17.77%, up 7836.0% from the prior year.
- Net Margin was 1034.95% for Q1 2026 at Monte Rosa Therapeutics, up from 1060.37% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 55.2% in Q1 2025 to a low of 3004.51% in Q1 2024.
- Historically, Net Margin has averaged 666.45% across 3 years, with a median of 258.89% in 2024.
- The sharpest annual moves came in 2025 and 2026: Net Margin soared 305972 bps in 2025, then tumbled 109016 bps in 2026.
- A 3-year view of Net Margin shows it stood at 22.16% in 2024, then plunged by 4886 bps to 1060.37% in 2025, then climbed by 2 bps to 1034.95% in 2026.
- The last three Net Margin figures came in at 1034.95% (Q1 2026), 1060.37% (Q4 2025), and 18.05% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Monte Rosa Therapeutics | 1.83 Bn | 1.15 Bn | - | -1,034.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,034.95% |
| Dec 31, 2025 | -1,060.37% |
| Sep 30, 2025 | -18.05% |
| Jun 30, 2025 | -53.01% |
| Mar 31, 2025 | 55.20% |
| Dec 31, 2024 | 22.16% |
| Sep 30, 2024 | -258.89% |
| Jun 30, 2024 | -645.58% |
| Mar 31, 2024 | -3,004.51% |